Table 3.
Perioperative outcomes
| Characteristic | Total (n 52) | EG (n 30) | LG (n 22) | p value |
|---|---|---|---|---|
| Operative time, median (IQR), min | 590 (537–615) | 581.5 (519–601) | 597.5 (559–660) | 0.341 |
| Conversion (n), % | 2 (3.8) | 2 (6.7) | 0 (0.0) | 0.502 |
| Estimated blood loss, mean, ml | 255 (180–395) | 300 (207.5–400) | 200 (130–362.5) | 0.095 |
| Complication (n), % | 30 (57.7) | 15 (50) | 15 (68.2) | 0.259 |
| Clavien-Dindo | 0.434 | |||
| 1 | 0 (0.0) | 0(0.0) | 0 (0.0) | |
| 2 | 14 (26.9) | 3 (10.0) | 11 (50.0) | |
| 3a | 7 (13.5) | 3 (10.0) | 4 (18.2) | |
| 3b | 2 (3.8) | 1 (3.3) | 1 (4.5) | |
| 4a | 4 (7.7) | 3 (10.0) | 1 (4.5) | |
| 4b | 1 (1.9) | 1 (3.3) | 0 (0.0) | |
| Severe complication (n), % | 14 (26.9) | 9 (30) | 5 (22.7) | 0.753 |
| CCI: median (IQR) | 20.9 (0–33.5) | 10.5 (0–33.5) | 20.9 (0–33.5) | 0.365 |
| mean (SD) | 21.4 (24.1) | 22.1 (28.9) | 20.6 (16.2) | |
| Reoperation (n) % | 8 (15.4) | 7 (23.3) | 1 (4.6) | 0.064 |
| POPF (n), % | 8 (15.4) | 6 (20) | 2 (9.1) | 0.429 |
| DGE (n), % | 12 (23.1) | 5 (16.7) | 7 (31.8) | 0.318 |
| BL (n) % | 5 (9.6) | 2 (6.7) | 3 (13.6) | 0.639 |
| PPH (n) % | 6 (11.5) | 4 (13.3) | 2 (9.1) | 0.636 |
| Length of stay, median (IQR) | 14.5 (10–22) | 14 (10–28) | 15 (9–21) | 0.573 |
| Readmission (n) % | 4 (8.0) | 1 (3.6) | 3 (13.6) | 0.308 |
| Mortality (n) % | 2 (3.8) | 2 (6.7) | 0 (0.0) | 0.502 |
n number, EG early group, LG late group, CCI comprehensive comorbidity index, POPF postoperative pancreatic fistula, DGE delayed gastric emptying, BL biliary leakage, PPH postpancreatectomy hemorrhage
*Calculated on the number of oncological patients